These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33602720)

  • 21. The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.
    Yan Q; Bartz S; Mao M; Li L; Kaelin WG
    Mol Cell Biol; 2007 Mar; 27(6):2092-102. PubMed ID: 17220275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin.
    Macgregor JN; Li Q; Chang AE; Braun TM; Hughes DP; McDonagh KT
    Cancer Res; 2006 May; 66(9):4913-21. PubMed ID: 16651448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF transcription factors, inflammation, and immunity.
    Palazon A; Goldrath AW; Nizet V; Johnson RS
    Immunity; 2014 Oct; 41(4):518-28. PubMed ID: 25367569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status.
    Moreno-Manzano V; Rodríguez-Jiménez FJ; Aceña-Bonilla JL; Fustero-Lardíes S; Erceg S; Dopazo J; Montaner D; Stojkovic M; Sánchez-Puelles JM
    J Biol Chem; 2010 Jan; 285(2):1333-42. PubMed ID: 19897487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor/MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of occludin, leading to hypoxia-induced inflammation.
    Xie L; Xue X; Taylor M; Ramakrishnan SK; Nagaoka K; Hao C; Gonzalez FJ; Shah YM
    Mol Cell Biol; 2014 Aug; 34(16):3013-23. PubMed ID: 24891620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
    Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
    Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
    Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reinforce the antitumor activity of CD8
    Nabe S; Yamada T; Suzuki J; Toriyama K; Yasuoka T; Kuwahara M; Shiraishi A; Takenaka K; Yasukawa M; Yamashita M
    Cancer Sci; 2018 Dec; 109(12):3737-3750. PubMed ID: 30302856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.
    Kim WY; Safran M; Buckley MR; Ebert BL; Glickman J; Bosenberg M; Regan M; Kaelin WG
    EMBO J; 2006 Oct; 25(19):4650-62. PubMed ID: 16977322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
    J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
    Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W
    Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
    Joshi S; Singh AR; Zulcic M; Durden DL
    Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-27 improves adoptive CD8
    Ding M; Fei Y; Zhu J; Ma J; Zhu G; Zhen N; Zhu J; Mao S; Sun F; Wang F; Pan Q
    Cancer Sci; 2022 Jul; 113(7):2258-2271. PubMed ID: 35441753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
    Sourbier C; Srivastava G; Ghosh MC; Ghosh S; Yang Y; Gupta G; Degraff W; Krishna MC; Mitchell JB; Rouault TA; Linehan WM
    Oncotarget; 2012 Nov; 3(11):1472-82. PubMed ID: 23178531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
    Yang X; Yang S; Wang C; Kuang S
    J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2α.
    Tarade D; Lee JE; Ohh M
    Nat Commun; 2019 Jul; 10(1):3293. PubMed ID: 31337753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity.
    Mysore VS; Szablowski J; Dervan PB; Frost PJ
    Mol Cancer Res; 2016 Mar; 14(3):253-66. PubMed ID: 26801054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.